Wikidata entity: Q113368879
Quantities
| P4250 | defined daily dose | 7.5 |
| P2054 | density | 1.35 |
| P2129 | immediately dangerous to life or health | 100 |
| P2101 | melting point | 161 |
| P2101 | melting point | 162 |
| P2101 | melting point | 322 |
| P2993 | partition coefficient water/octanol | 0.7 |
| P2993 | partition coefficient water/octanol | 2.7 |
| P1117 | pKa | 5 |
| P2177 | solubility | 0.002 |
| P2177 | solubility | 16.9 |
| P2177 | solubility | 17 |
| P2177 | solubility | 22.2 |
| P2177 | solubility | 54.6 |
| P3013 | surface tension | 72.8 |
| P2404 | time-weighted average exposure limit | 0.1 |
| P2119 | vapor pressure | 0.09 |
| P3780 | active ingredient in | ... | Q47521415 (Coumadin) | Coumadin |
| P3780 | active ingredient in | ... | Q48828105 (Jantoven) | Jantoven |
| P373 | Commons category | String | Warfarin | ??? |
| P1889 | different from | ... | Q407431 ((RS)-warfarin) | (RS)-warfarin |
| P1552 | has characteristic | ... | Q21073024 (flammable solid) | flammable solid |
| P1542 | has effect | ... | Q21175420 (warfarin exposure) | warfarin exposure |
| P527 | has part(s) | ... | Q27093493 ((S)-warfarin) | (S)-warfarin |
| P527 | has part(s) | ... | Q27105121 ((R)-warfarin) | (R)-warfarin |
| P31 | instance of | ... | Q119892838 (type of mixture of chemical entities) | type of mixture of chemical entities |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P2175 | medical condition treated | ... | Q190805 (heart disease) | heart disease |
| P2175 | medical condition treated | ... | Q18478450 (postoperative complications) | postoperative complications |
| P2175 | medical condition treated | ... | Q261327 (thrombosis) | thrombosis |
| P2175 | medical condition treated | ... | Q220570 (pulmonary embolism) | pulmonary embolism |
| P2175 | medical condition treated | ... | Q377978 (thrombophlebitis) | thrombophlebitis |
| P2175 | medical condition treated | ... | Q7514772 (silent stroke) | silent stroke |
| P2175 | medical condition treated | ... | Q593958 (transient cerebral isolation) | transient cerebral isolation |
| P2175 | medical condition treated | ... | Q815819 (atrial fibrillation) | atrial fibrillation |
| P2175 | medical condition treated | ... | Q1130519 (heart valve disease) | heart valve disease |
| P2175 | medical condition treated | ... | Q1506572 (atrial flutter) | atrial flutter |
| P129 | physically interacts with | ... | Q21175110 (Vitamin K epoxide reductase complex subunit 1) | Vitamin K epoxide reductase complex subunit 1 |
| P3489 | pregnancy category | ... | Q28123619 (US pregnancy category X) | US pregnancy category X |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P6802 | related image | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Warfarin%20bottles%20NIGMS.jpg | ??? |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q1369403 (intravenous injection) | intravenous injection |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q169569 (metronidazole) | metronidazole |
| P769 | significant drug interaction | ... | Q177094 (imatinib) | imatinib |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q190016 (heparin) | heparin |
| P769 | significant drug interaction | ... | Q18939 (azathioprine) | azathioprine |
| P769 | significant drug interaction | ... | Q193045 (tetracycline) | tetracycline |
| P769 | significant drug interaction | ... | Q238512 (fluorouracil) | fluorouracil |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q2295855 (eptifibatide) | eptifibatide |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q256602 (ciprofloxacin) | ciprofloxacin |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q57055 (paracetamol) | paracetamol |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q2602750 (diflunisal) | diflunisal |
| P769 | significant drug interaction | ... | Q2736402 (demeclocycline) | demeclocycline |
| P769 | significant drug interaction | ... | Q3563148 (vortioxetine) | vortioxetine |
| P769 | significant drug interaction | ... | Q307088 (abciximab) | abciximab |
| P769 | significant drug interaction | ... | Q327506 (D-glucosamine) | D-glucosamine |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q11426176 (prednisolone) | prednisolone |
| P769 | significant drug interaction | ... | Q20817139 (iloprost) | iloprost |
| P769 | significant drug interaction | ... | Q20817252 (tinzaparin) | tinzaparin |
| P769 | significant drug interaction | ... | Q284321 (mefenamic acid) | mefenamic acid |
| P769 | significant drug interaction | ... | Q75163056 (rac-miconazole) | rac-miconazole |
| P769 | significant drug interaction | ... | Q105969996 (enoxaparin) | enoxaparin |
| P769 | significant drug interaction | ... | Q110969665 (urokinase) | urokinase |
| P769 | significant drug interaction | ... | Q384295 (gemfibrozil) | gemfibrozil |
| P769 | significant drug interaction | ... | Q407241 (phenobarbital) | phenobarbital |
| P769 | significant drug interaction | ... | Q27114691 (mercaptopurine hydrate) | mercaptopurine hydrate |
| P769 | significant drug interaction | ... | Q45769835 (alteplase) | alteplase |
| P769 | significant drug interaction | ... | Q47495791 (levofloxacin hemihydrate) | levofloxacin hemihydrate |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q3992411 (tolmetin) | tolmetin |
| P769 | significant drug interaction | ... | Q5984881 (ibrutinib) | ibrutinib |
| P769 | significant drug interaction | ... | Q6556102 (liotrix) | liotrix |
| P769 | significant drug interaction | ... | Q409492 (cimetidine) | cimetidine |
| P769 | significant drug interaction | ... | Q409665 (disulfiram) | disulfiram |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q410237 (clopidogrel) | clopidogrel |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q410412 (carbamazepin) | carbamazepin |
| P769 | significant drug interaction | ... | Q410534 (miconazole) | miconazole |
| P769 | significant drug interaction | ... | Q304088 (acenocoumarol) | acenocoumarol |
| P769 | significant drug interaction | ... | Q411646 (oxytetracycline) | oxytetracycline |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q412178 (tamoxifen) | tamoxifen |
| P769 | significant drug interaction | ... | Q411447 (DL-ofloxacin) | DL-ofloxacin |
| P769 | significant drug interaction | ... | Q411478 (fluconazole) | fluconazole |
| P769 | significant drug interaction | ... | Q416132 (betamethasone) | betamethasone |
| P769 | significant drug interaction | ... | Q416232 (prasugrel) | prasugrel |
| P769 | significant drug interaction | ... | Q416485 (Streptokinase) | Streptokinase |
| P769 | significant drug interaction | ... | Q412236 (voriconazole) | voriconazole |
| P769 | significant drug interaction | ... | Q413370 ((RS)-tegafur) | (RS)-tegafur |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q414462 (apixaban) | apixaban |
| P769 | significant drug interaction | ... | Q415159 (rosuvastatin) | rosuvastatin |
| P769 | significant drug interaction | ... | Q420383 (primidone) | primidone |
| P769 | significant drug interaction | ... | Q420542 (ticagrelor) | ticagrelor |
| P769 | significant drug interaction | ... | Q420595 (tigecycline) | tigecycline |
| P769 | significant drug interaction | ... | Q417222 (methylprednisolone) | methylprednisolone |
| P769 | significant drug interaction | ... | Q417740 (lovastatin) | lovastatin |
| P769 | significant drug interaction | ... | Q421713 (ceftriaxone) | ceftriaxone |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q415336 (minocycline) | minocycline |
| P769 | significant drug interaction | ... | Q415366 (tirofiban) | tirofiban |
| P769 | significant drug interaction | ... | Q415843 (sulfamethoxazole) | sulfamethoxazole |
| P769 | significant drug interaction | ... | Q422252 (dexamethasone) | dexamethasone |
| P769 | significant drug interaction | ... | Q422442 (doxycycline) | doxycycline |
| P769 | significant drug interaction | ... | Q417897 (norfloxacin) | norfloxacin |
| P769 | significant drug interaction | ... | Q417942 (fluvastatin) | fluvastatin |
| P769 | significant drug interaction | ... | Q419652 (danazol) | danazol |
| P769 | significant drug interaction | ... | Q419724 (fenofibrate) | fenofibrate |
| P769 | significant drug interaction | ... | Q422652 (rifampicin) | rifampicin |
| P769 | significant drug interaction | ... | Q422654 (saquinavir) | saquinavir |
| P769 | significant drug interaction | ... | Q423467 (atazanavir) | atazanavir |
| P769 | significant drug interaction | ... | Q422645 (efavirenz) | efavirenz |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q424972 (prednisone) | prednisone |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q420207 (capecitabine) | capecitabine |
| P769 | significant drug interaction | ... | Q420262 (rivaroxaban) | rivaroxaban |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q577387 (bezafibrate) | bezafibrate |
| P769 | significant drug interaction | ... | Q621834 (aprepitant) | aprepitant |
| P769 | significant drug interaction | ... | Q670131 (simvastatin) | simvastatin |
| P769 | significant drug interaction | ... | Q898407 (venlafaxine) | venlafaxine |
| P769 | significant drug interaction | ... | Q773449 (L-thyroxine) | L-thyroxine |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q930170 (liothyronine sodium) | liothyronine sodium |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1074056 (triamcinolone) | triamcinolone |
| P769 | significant drug interaction | ... | Q1640947 (phenindione) | phenindione |
| P769 | significant drug interaction | ... | Q1644947 (tenecteplase) | tenecteplase |
| P769 | significant drug interaction | ... | Q1749609 (oxaprozin) | oxaprozin |
| P769 | significant drug interaction | ... | Q1851701 (dalteparin) | dalteparin |
| P769 | significant drug interaction | ... | Q2014797 (ketorolac) | ketorolac |
| P279 | subclass of | ... | Q136084440 (warfarin) | warfarin |
| P279 | subclass of | ... | Q467717 (racemate) | racemate |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q215118 (anticoagulant) | anticoagulant |
| P2868 | subject has role | ... | Q72941151 (developmental toxicant) | developmental toxicant |
| P2868 | subject has role | ... | Q924146 (rodenticide) | rodenticide |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | warfarin | ??? |
| P13757 | A Dictionary of Dentistry entry ID | 4671 |
| P8061 | AGROVOC ID | c_8299 |
| P267 | ATC code | B01AA03 |
| P7524 | CA PROP 65 ID | warfarin |
| P683 | ChEBI ID | 10033 |
| P9272 | DeCS ID | 15261 |
| P715 | DrugBank ID | DB00682 |
| P232 | EC number | 201-377-6 |
| P2566 | ECHA Substance Infocard ID | 100.001.253 |
| P9635 | electronic Essential Medicines List medicine ID | 128 |
| P1417 | Encyclopædia Britannica Online ID | science/warfarin |
| P646 | Freebase ID | /m/01jjmt |
| P2671 | Google Knowledge Graph ID | /g/121xqm3j |
| P12385 | Gran Enciclopèdia Catalana ID | warfarina |
| P1296 | Gran Enciclopèdia Catalana ID (former scheme) | 0071843 |
| P595 | Guide to Pharmacology Ligand ID | 6853 |
| P7025 | HCIS ID | 4708 |
| P2062 | HSDB ID | 1786 |
| P2057 | Human Metabolome Database ID | HMDB0001935 |
| P5220 | ICSC ID | 0821 |
| P8408 | KBpedia ID | Warfarin |
| P665 | KEGG ID | C01541 |
| P10245 | MedlinePlus drug identifier | a682277 |
| P486 | MeSH descriptor ID | D014859 |
| P672 | MeSH tree code | D03.383.663.283.446.520.914 |
| P672 | MeSH tree code | D03.633.100.150.446.520.914 |
| P6366 | Microsoft Academic ID (discontinued) | 2776301958 |
| P6366 | Microsoft Academic ID (discontinued) | 2908821671 |
| P2004 | NALT ID | 10266 |
| P8885 | Namuwiki ID | 와파린 |
| P2115 | NDF-RT ID | N0000148057 |
| P3222 | NE.se ID | warfarin |
| P691 | NL CR AUT ID | ph127493 |
| P2840 | NSC number | 59813 |
| P2840 | NSC number | 757385 |
| P10283 | OpenAlex ID | C2776301958 |
| P4235 | PatientsLikeMe treatment ID | warfarin |
| P3417 | Quora topic ID | Coumadin |
| P3417 | Quora topic ID | Warfarin |
| P657 | RTECS number | GN4550000 |
| P3345 | RxNorm CUI | 11289 |
| P10376 | ScienceDirect topic ID | agricultural-and-biological-sciences/warfarin |
| P10376 | ScienceDirect topic ID | chemistry/warfarin |
| P10376 | ScienceDirect topic ID | medicine-and-dentistry/warfarin |
| P10376 | ScienceDirect topic ID | neuroscience/warfarin |
| P10376 | ScienceDirect topic ID | nursing-and-health-professions/warfarin |
| P10376 | ScienceDirect topic ID | pharmacology-toxicology-and-pharmaceutical-science/warfarin |
| P10380 | Springer Nature Subjects Taxonomy ID | warfarin-in-dentistry |
| P5082 | Store medisinske leksikon ID | warfarin |
| P4527 | UK Parliament thesaurus ID | 419909 |
| P2892 | UMLS CUI | C0043031 |
| P652 | UNII | 5Q7ZVV76EI |
| P11143 | WikiProjectMed ID | Warfarin |
| P3471 | WikiSkripta article ID | 11547 |
| P8814 | WordNet 3.1 Synset ID | 04558491-n |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 341 |
| P2347 | YSO ID | 38611 |
| P679 | ZVG number | 35400 |
Why not click here or view trends?
log id: 1926549